文献速递胸部DRCT

症状成人胸片检出肺癌的前瞻性队列敏感度与特异度评估

A prospective cohort evaluation of the sensitivity and specificity of the chest X-ray for the detection of lung cancer in symptomatic adults.
PubMed 文献 · Eur J Radiol · 2021-09-20

在初级保健开放获取计划中,对8948例有症状且年龄>50岁患者的胸片报告进行前瞻性队列评估,以CT检查及1-2年内恶性肿瘤诊断为参考标准。胸片阳性强烈增加恶性肿瘤概率,但阴性不能排除肺癌;2年内阴性检测将肺癌风险降至0.8%。

要点

  • 胸片阳性强烈提示恶性可能,但阴性不能排除肺癌。
  • NSCLC的1年敏感度76%、特异度95%,2年敏感度降至60%。
  • 2年阴性检测后肺癌风险为0.8%。

诊断标准与关键数值

  • NSCLC的1年敏感度76%(95%CI 68-84),特异度95%(95%CI 95-96)。
  • NSCLC的2年敏感度60%(95%CI 52-69),特异度95%(95%CI 95-96)。
  • 2年阳性似然比12.8,阴性似然比0.4。
  • NSCLC与所有原发恶性肿瘤的结果无差异。
  • 在有症状人群中,阴性检测将2年肺癌风险降至0.8%。

临床应用与阅片要点

  • 胸片阳性应积极行CT进一步检查以明确恶性可能。
  • 胸片阴性不能排除肺癌,需结合临床风险综合判断。
  • 对有症状且年龄>50岁患者,阴性胸片后2年肺癌风险为0.8%,可据此估算风险。

局限性

  • 研究为单中心前瞻性队列,结果外推需谨慎。
  • 阳性检测定义为胸片导致CT检查,可能引入验证偏倚。
  • 参考标准依赖1-2年内恶性肿瘤观察,可能遗漏更长随访期肿瘤。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: The accuracy of the chest x-ray (CXR) in the identification of lung cancer amongst symptomatic individuals is uncertain.

PURPOSE: To determine the diagnostic accuracy of the CXR for the detection of non-small cell carcinomas (NSCLC) and all primary intrathoracic malignancies.

METHODS: A prospective cohort study of consecutive CXR reports obtained within a primary care open access initiative. Eligibility criteria were symptoms specified by National Institute for Clinical Excellence as indicative of possible lung cancer and age over 50-yrs. A positive test was a CXR which led directly or indirectly to investigation with CT. The reference standards were malignancies observed within a one- or two-year post-test period.

RESULTS: 8,948 CXR outcomes were evaluated. 496 positive studies led to a diagnosis of 101 patients with primary intrathoracic malignancy including 80 with NSCLC. Within two-years, a cumulative total of 168 patients with primary intrathoracic malignancies including 133 NSCLC were observed. The sensitivity and specificity for NSCLC were 76% (95 %CI 68-84) and 95% (95 %CI 95-96) within 1-year and 60% (95 %CI 52-69) and 95% (95 %CI 95-96) within 2-years. The 2-yr positive and negative likelihood ratios were 12.8 and 0.4. The results did not differ for NSCLC compared to all primary malignancies. Within this symptomatic population a negative test reduced the 2-year risk of lung cancer to 0.8%.

CONCLUSIONS: A positive test strongly increases the probability of malignancy whereas a negative test does not conclusively exclude the disease. The findings allow the risk of malignancy following a negative test to be estimated.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Bhartia BSK, Hatton NLF, Aslam R, et al. A prospective cohort evaluation of the sensitivity and specificity of the chest X-ray for the detection of lung cancer in symptomatic adults. Eur J Radiol. 2021. PMID: 34560505. doi:10.1016/j.ejrad.2021.109953

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。